Apimeds Pharmaceuticals US Inc.
01/02/2026 | Press release | Distributed by Public on 01/02/2026 15:31
Management Change/Compensation (Form 8-K)
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On December 30, 2025, the stockholders of Apimeds Pharmaceuticals US, Inc., a Delaware corporation (the "Company"), acting by written consent, removed Erik Emerson from the Company's board of directors, effective as of such date. The removal was effected by the affirmative vote of stockholders holding a majority of the outstanding shares of common stock of the Company's voting power entitled to vote generally in the election of directors, and was taken with or without cause, in accordance with the Company's organizational documents and applicable law.
The following remain members of the Company's board of directors:
| · | Elona Kogan |
| · | Jakap Koo |
| · | Carol O'Donnell |
| · | Dr. Bennett Weintraub, PHD |
Apimeds Pharmaceuticals US Inc. published this content on January 02, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on January 02, 2026 at 21:31 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]